SLI
1.986,50
PKT
-7,62
PKT
-0,38
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.04.22 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.04.22 | Richemont Buy | UBS AG | |
| 04.04.22 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
| 04.04.22 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
| 01.04.22 | Novartis Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | UBS Overweight | JP Morgan Chase & Co. | |
| 01.04.22 | UBS Underweight | JP Morgan Chase & Co. | |
| 01.04.22 | UBS Outperform | Credit Suisse Group | |
| 31.03.22 | Roche Buy | Deutsche Bank AG | |
| 31.03.22 | ams-OSRAM Overweight | JP Morgan Chase & Co. | |
| 31.03.22 | UBS Neutral | Goldman Sachs Group Inc. | |
| 31.03.22 | UBS Buy | Goldman Sachs Group Inc. | |
| 30.03.22 | Nestlé Neutral | Credit Suisse Group | |
| 30.03.22 | Roche Overweight | Barclays Capital | |
| 30.03.22 | Roche Buy | Merrill Lynch & Co., Inc. | |
| 30.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 30.03.22 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 30.03.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 30.03.22 | Roche Outperform | Bernstein Research | |
| 30.03.22 | UBS Sector Perform | RBC Capital Markets | |
| 30.03.22 | UBS Outperform | RBC Capital Markets | |
| 30.03.22 | UBS Buy | Jefferies & Company Inc. | |
| 30.03.22 | UBS Hold | Jefferies & Company Inc. | |
| 30.03.22 | Nestlé Neutral | Credit Suisse Group | |
| 29.03.22 | Givaudan Neutral | UBS AG | |
| 29.03.22 | Givaudan Hold | Deutsche Bank AG | |
| 29.03.22 | Roche Neutral | JP Morgan Chase & Co. | |
| 29.03.22 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 28.03.22 | Givaudan Neutral | UBS AG | |
| 28.03.22 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 28.03.22 | Nestlé Underperform | Jefferies & Company Inc. | |
| 25.03.22 | ABB (Asea Brown Boveri) Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.03.22 | Nestlé Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 24.03.22 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 23.03.22 | Swiss Re Hold | Jefferies & Company Inc. | |
| 23.03.22 | Givaudan Neutral | Goldman Sachs Group Inc. | |
| 23.03.22 | Givaudan Underperform | Jefferies & Company Inc. | |
| 22.03.22 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 22.03.22 | Novartis Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |